Acute-on-chronic Liver Failure
- 17 October 2016
- journal article
- review article
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 18 (12) , 61
Abstract
Acute-on-chronic liver failure (ACLF) is a distinct entity that differs from acute liver failure and decompensated cirrhosis in timing, presence of treatable acute precipitant, and course of disease, with a potential for self-recovery. The core concept is acute deterioration of existing liver function in a patient of chronic liver disease with or without cirrhosis in response to an acute insult. The insult should be a hepatic one and presentation in the form of liver failure (jaundice, encephalopathy, coagulopathy, ascites) with or without extrahepatic organ failure in a defined time frame. ACLF is characterized by a state of deregulated inflammation. Initial cytokine burst presenting as SIRS, progression to CARS and associated immunoparalysis leads to sepsis and multi-organ failure. Early identification of the acute insult and mitigation of the same, use of nucleoside analogue in HBV-ACLF, steroid in severe alcoholic hepatitis, steroid in severe autoimmune hepatitis and/or bridging therapy lead to recovery, with a 90-day transplant-free survival rate of up to 50 %. First-week presentation is crucial concerning SIRS/sepsis, development, multiorgan failure and consideration of transplant. A protocol-based multi-disciplinary approach including critical care hepatology, early liver transplant before multi-organ involvement, or priority for organ allocation may improve the outcome. Presentation with extrahepatic organ involvement or inclusion of sepsis as an acute insult in definition restricts the therapy, i.e., liver transplant or bridging therapy, and needs serious consideration. Augmentation of regeneration, cell-based therapy, immunotherapy, and gut microbiota modulation are the emerging areas and need further research.Keywords
This publication has 99 references indexed in Scilit:
- Impacts of Pretransplant Infections on Clinical Outcomes of Patients with Acute-On-Chronic Liver Failure Who Received Living-Donor Liver TransplantationPLOS ONE, 2013
- Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regressionExperimental and Therapeutic Medicine, 2013
- Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait listLiver Transplantation, 2013
- Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled TrialPLOS ONE, 2013
- Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver FailurePLOS ONE, 2012
- Role of Stem Cell Factor and Granulocyte Colony–Stimulating Factor in Remodeling During Liver RegenerationHepatology, 2011
- Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis BHepatology International, 2010
- Role of Cytokines in the Pathophysiology of Acute-on-Chronic Liver FailureBlood Purification, 2009
- Liver transplantation for acute-on-chronic liver failureHepatology International, 2009
- Altered immune function of monocytes in different stages of patients with acute on chronic liver failureClinical and Experimental Immunology, 2006